EVALUATION OF CLINICAL EFFICACY OF RAJATA YOGA IN PRAMEHA W.S.R. TO DIABETES MELLITUS

M. Bhavani
{"title":"EVALUATION OF CLINICAL EFFICACY OF RAJATA YOGA IN PRAMEHA W.S.R. TO DIABETES MELLITUS","authors":"M. Bhavani","doi":"10.20959/WJPR201710-9441","DOIUrl":null,"url":null,"abstract":"Rasa Shastra has been serving humanity from centuries with its unique metallic and herbo-mineral formulations. Prameha is one among the 8 Mahagadas as numerated by our Acharyas. The syndrome Diabetes mellitus has been largely covered under the broad heading of Prameha. Diabetes mellitus is a metabolic disorder of carbohydrate, fat & protein characterized by hyperglycemia with or without glycosuria. According to the International Diabetic Federation (IDF), the disease affects 285 million people of the world‟s population in the 20 – 79 years age group and this number is expected to grow to 380 million by 2025. Rajata Yoga is mentioned in Rasa Tarangini and indicated in all types of Prameha. Rajata bhasma and Trijataka churna are the main ingredients of Rajata Yoga. Its clinical efficacy was evaluated in 30 patients of Prameha based on the signs and symptoms mentioned in classics. Rajata Yoga showed statistically extremely significant relief (p<0.0001) in Prabhuta mutrata, Avila mutrata, Karapada daha & suptata, Dourbalya, Kruchravyavayata, Pindikodveshtana, FBS, PPBS. It showed very significant relief (p< 0.001) in Sweda atipravrutti and significant relief in (p<0.05) in Pipasaadhikyata, Kshudaadhikyata.","PeriodicalId":23796,"journal":{"name":"World journal of pharmaceutical research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of pharmaceutical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20959/WJPR201710-9441","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Rasa Shastra has been serving humanity from centuries with its unique metallic and herbo-mineral formulations. Prameha is one among the 8 Mahagadas as numerated by our Acharyas. The syndrome Diabetes mellitus has been largely covered under the broad heading of Prameha. Diabetes mellitus is a metabolic disorder of carbohydrate, fat & protein characterized by hyperglycemia with or without glycosuria. According to the International Diabetic Federation (IDF), the disease affects 285 million people of the world‟s population in the 20 – 79 years age group and this number is expected to grow to 380 million by 2025. Rajata Yoga is mentioned in Rasa Tarangini and indicated in all types of Prameha. Rajata bhasma and Trijataka churna are the main ingredients of Rajata Yoga. Its clinical efficacy was evaluated in 30 patients of Prameha based on the signs and symptoms mentioned in classics. Rajata Yoga showed statistically extremely significant relief (p<0.0001) in Prabhuta mutrata, Avila mutrata, Karapada daha & suptata, Dourbalya, Kruchravyavayata, Pindikodveshtana, FBS, PPBS. It showed very significant relief (p< 0.001) in Sweda atipravrutti and significant relief in (p<0.05) in Pipasaadhikyata, Kshudaadhikyata.
拉贾塔瑜伽治疗糖尿病的临床疗效评价
几个世纪以来,Rasa Shastra一直以其独特的金属和草药矿物配方为人类服务。Prameha是我们的阿查里亚所计算的8大摩诃伽达之一。糖尿病综合征已经在Prameha的大标题下进行了大量的介绍。糖尿病是一种碳水化合物、脂肪和蛋白质代谢紊乱,以高血糖伴或不伴糖尿为特征。根据国际糖尿病联合会(IDF)的数据,全球20 - 79岁年龄组中有2.85亿人患有糖尿病,预计到2025年这一数字将增长到3.8亿。《塔兰尼尼书》中提到了拉贾塔瑜伽,并在所有类型的普拉梅哈中都有提及。Rajata bhasma和Trijataka churna是Rajata瑜伽的主要成分。根据经上所述的体征和症状,对30例Prameha患者的临床疗效进行评价。Rajata瑜伽在Prabhuta mutrata, Avila mutrata, Karapada daha & suptata, Dourbalya, Kruchravyavayata, Pindikodveshtana, FBS, PPBS上显示了统计学上极显著的缓解(p<0.0001)。结果表明,在瑞典有极显著的缓解(p< 0.001),在Pipasaadhikyata, Kshudaadhikyata有显著的缓解(p<0.05)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信